个体化-话题@MedSci

#个体化#

206篇内容 | 4100人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1435412, encodeId=359614354123c, content=<a href='/topic/show?id=9a5c212e88f' target=_blank style='color:#2F92EE;'>#个体化#</a>, objectTitle=一例特殊非转移性去势抵抗性前列腺癌患者，个体化新型内分泌治疗后生存良好！, objectType=article, longId=190970, objectId=6cd81909e0c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cd81909e0c0, replyNumber=0, likeNumber=85, createdTime=2020-03-29, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cd81909e0c0, moduleTitle=一例特殊非转移性去势抵抗性前列腺癌患者，个体化新型内分泌治疗后生存良好！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cd81909e0c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435411, encodeId=ff271435411fb, content=<a href='/topic/show?id=9a5c212e88f' target=_blank style='color:#2F92EE;'>#个体化#</a>, objectTitle=2020年ASCO-SITC：针对高危黑色素瘤患者的个体化疫苗取得喜人结果, objectType=article, longId=187728, objectId=50b618e7282f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50b618e7282f, replyNumber=0, likeNumber=88, createdTime=2020-02-10, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50b618e7282f, moduleTitle=2020年ASCO-SITC：针对高危黑色素瘤患者的个体化疫苗取得喜人结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50b618e7282f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435410, encodeId=ac8f1435410a4, content=<a href='/topic/show?id=9a5c212e88f' target=_blank style='color:#2F92EE;'>#个体化#</a>, objectTitle=椎动脉夹层动脉瘤的个体化栓塞治疗, objectType=article, longId=184360, objectId=ca31184360fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca31184360fc, replyNumber=0, likeNumber=115, createdTime=2019-12-08, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca31184360fc, moduleTitle=椎动脉夹层动脉瘤的个体化栓塞治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca31184360fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435409, encodeId=2aae143540954, content=<a href='/topic/show?id=9a5c212e88f' target=_blank style='color:#2F92EE;'>#个体化#</a>, objectTitle=北京精准用药研究与应用中心成立助推实现个体化用药, objectType=article, longId=182812, objectId=4363182812fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4363182812fe, replyNumber=0, likeNumber=73, createdTime=2019-11-12, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4363182812fe, moduleTitle=北京精准用药研究与应用中心成立助推实现个体化用药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4363182812fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435408, encodeId=b2061435408c8, content=<a href='/topic/show?id=9a5c212e88f' target=_blank style='color:#2F92EE;'>#个体化#</a>, objectTitle=【CHC2019】个体化治疗是老年高血压管理的“灵魂”, objectType=article, longId=182675, objectId=a74e1826e582, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a74e1826e582, replyNumber=0, likeNumber=100, createdTime=2019-11-10, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a74e1826e582, moduleTitle=【CHC2019】个体化治疗是老年高血压管理的“灵魂”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a74e1826e582)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435407, encodeId=1041143540e00, content=<a href='/topic/show?id=9a5c212e88f' target=_blank style='color:#2F92EE;'>#个体化#</a>, objectTitle=J Clin Oncol:个体化内分泌辅助治疗让绝经前HR+/HER2-乳腺癌患者**获益, objectType=article, longId=182233, objectId=c84718223331, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c84718223331, replyNumber=0, likeNumber=81, createdTime=2019-11-03, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c84718223331, moduleTitle=J Clin Oncol:个体化内分泌辅助治疗让绝经前HR+/HER2-乳腺癌患者**获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c84718223331)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435406, encodeId=4e45143540697, content=<a href='/topic/show?id=9a5c212e88f' target=_blank style='color:#2F92EE;'>#个体化#</a>, objectTitle=Nat Med：肿瘤全基因组测序助力癌症个体化治疗, objectType=article, longId=182167, objectId=267518216eff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=267518216eff, replyNumber=0, likeNumber=79, createdTime=2019-10-31, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=267518216eff, moduleTitle=Nat Med：肿瘤全基因组测序助力癌症个体化治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=267518216eff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435405, encodeId=41cf143540548, content=<a href='/topic/show?id=9a5c212e88f' target=_blank style='color:#2F92EE;'>#个体化#</a>, objectTitle=靶向新药百花齐放，NSCLC治疗和奥希替尼耐药后治疗应更个体化, objectType=article, longId=181299, objectId=64f618129957, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64f618129957, replyNumber=0, likeNumber=86, createdTime=2019-10-17, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64f618129957, moduleTitle=靶向新药百花齐放，NSCLC治疗和奥希替尼耐药后治疗应更个体化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64f618129957)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435404, encodeId=d2721435404fe, content=<a href='/topic/show?id=9a5c212e88f' target=_blank style='color:#2F92EE;'>#个体化#</a>, objectTitle=这些只能治疗一名患者的疗法，或将带来个体化医疗的新时代, objectType=article, longId=180977, objectId=0a061809e77c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a061809e77c, replyNumber=0, likeNumber=70, createdTime=2019-10-13, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a061809e77c, moduleTitle=这些只能治疗一名患者的疗法，或将带来个体化医疗的新时代, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a061809e77c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435403, encodeId=05b51435403e6, content=<a href='/topic/show?id=9a5c212e88f' target=_blank style='color:#2F92EE;'>#个体化#</a>, objectTitle=Radiology：主动脉CTA--个体化触发延迟效果怎么样？, objectType=article, longId=179819, objectId=065e1e981921, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=065e1e981921, replyNumber=0, likeNumber=100, createdTime=2019-09-23, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=065e1e981921, moduleTitle=Radiology：主动脉CTA--个体化触发延迟效果怎么样？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=065e1e981921)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435402, encodeId=992a143540242, content=<a href='/topic/show?id=9a5c212e88f' target=_blank style='color:#2F92EE;'>#个体化#</a>, objectTitle=2019 CSCO：多项重磅研究成果发布，引领肿瘤个体化医疗新时代, objectType=article, longId=179784, objectId=1a881e9784eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a881e9784eb, replyNumber=0, likeNumber=73, createdTime=2019-09-22, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a881e9784eb, moduleTitle=2019 CSCO：多项重磅研究成果发布，引领肿瘤个体化医疗新时代, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a881e9784eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435401, encodeId=5730143540147, content=<a href='/topic/show?id=9a5c212e88f' target=_blank style='color:#2F92EE;'>#个体化#</a>, objectTitle=精准治疗时代生物标志物助力肿瘤个体化诊疗, objectType=article, longId=176337, objectId=dc221e6337b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc221e6337b9, replyNumber=0, likeNumber=0, createdTime=2019-07-29, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc221e6337b9, moduleTitle=精准治疗时代生物标志物助力肿瘤个体化诊疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc221e6337b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435400, encodeId=331d143540007, content=<a href='/topic/show?id=9a5c212e88f' target=_blank style='color:#2F92EE;'>#个体化#</a>, objectTitle=完全个体化肿瘤免疫疗法：一种针对个体化抗原的自体基因编辑的TCR T细胞疗法（NeoTCR-P1）, objectType=article, longId=175924, objectId=f0c91e5924d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0c91e5924d3, replyNumber=0, likeNumber=74, createdTime=2019-07-23, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0c91e5924d3, moduleTitle=完全个体化肿瘤免疫疗法：一种针对个体化抗原的自体基因编辑的TCR T细胞疗法（NeoTCR-P1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0c91e5924d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435399, encodeId=09f6143539908, content=<a href='/topic/show?id=9a5c212e88f' target=_blank style='color:#2F92EE;'>#个体化#</a>, objectTitle=治愈时代的丙肝未来管理模式：个体化与精准化, objectType=article, longId=168978, objectId=957a1689e817, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=957a1689e817, replyNumber=0, likeNumber=71, createdTime=2019-06-24, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=957a1689e817, moduleTitle=治愈时代的丙肝未来管理模式：个体化与精准化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=957a1689e817)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435398, encodeId=c62d14353989f, content=<a href='/topic/show?id=9a5c212e88f' target=_blank style='color:#2F92EE;'>#个体化#</a>, objectTitle=2019 ASCO ：Moderna宣布其mRNA个体化癌症疫苗I期临床研究的中期阳性数据, objectType=article, longId=167542, objectId=a91c16e54224, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a91c16e54224, replyNumber=0, likeNumber=89, createdTime=2019-06-04, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a91c16e54224, moduleTitle=2019 ASCO ：Moderna宣布其mRNA个体化癌症疫苗I期临床研究的中期阳性数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a91c16e54224)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435397, encodeId=bb2b143539ece, content=<a href='/topic/show?id=9a5c212e88f' target=_blank style='color:#2F92EE;'>#个体化#</a>, objectTitle=溃疡性结肠炎的个体化治疗现状与展望, objectType=article, longId=166669, objectId=95e816666971, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95e816666971, replyNumber=0, likeNumber=73, createdTime=2019-05-25, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95e816666971, moduleTitle=溃疡性结肠炎的个体化治疗现状与展望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95e816666971)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435396, encodeId=00c5143539605, content=<a href='/topic/show?id=9a5c212e88f' target=_blank style='color:#2F92EE;'>#个体化#</a>, objectTitle=Acta Radiol：阜外医院吕滨等研究称，做冠脉CT时，个体化应用对比剂效果好, objectType=article, longId=166533, objectId=0a6d1665335e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a6d1665335e, replyNumber=0, likeNumber=72, createdTime=2019-05-22, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a6d1665335e, moduleTitle=Acta Radiol：阜外医院吕滨等研究称，做冠脉CT时，个体化应用对比剂效果好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a6d1665335e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435395, encodeId=0955143539530, content=<a href='/topic/show?id=9a5c212e88f' target=_blank style='color:#2F92EE;'>#个体化#</a>, objectTitle=Diabetes Care：糖尿病个体化饮食计划——ADA的全新建议, objectType=article, longId=165324, objectId=879a165324be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=879a165324be, replyNumber=0, likeNumber=0, createdTime=2019-05-05, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=879a165324be, moduleTitle=Diabetes Care：糖尿病个体化饮食计划——ADA的全新建议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=879a165324be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435394, encodeId=1af514353940f, content=<a href='/topic/show?id=9a5c212e88f' target=_blank style='color:#2F92EE;'>#个体化#</a>, objectTitle=Transgene与NEC在2019年合作开始个体化肿瘤疫苗TG4050的临床开发, objectType=article, longId=161801, objectId=b01116180117, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b01116180117, replyNumber=0, likeNumber=82, createdTime=2019-03-08, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b01116180117, moduleTitle=Transgene与NEC在2019年合作开始个体化肿瘤疫苗TG4050的临床开发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b01116180117)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435393, encodeId=bf93143539362, content=<a href='/topic/show?id=9a5c212e88f' target=_blank style='color:#2F92EE;'>#个体化#</a>, objectTitle=Blood：多发性骨髓瘤治疗迈入“精准”时代——分子生物学检测指导个体化治疗, objectType=article, longId=159712, objectId=5b9d159e12a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b9d159e12a2, replyNumber=0, likeNumber=135, createdTime=2019-02-11, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b9d159e12a2, moduleTitle=Blood：多发性骨髓瘤治疗迈入“精准”时代——分子生物学检测指导个体化治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b9d159e12a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

个体化

2020-05-29

zhouqu_8 (审核中...)

前往app查看评论内容

#个体化#

一例特殊非转移性去势抵抗性前列腺癌患者，个体化新型内分泌治疗后生存良好！

2020-03-29

zhouqu_8 (审核中...)

前往app查看评论内容

#个体化#

2020年ASCO-SITC：针对高危黑色素瘤患者的个体化疫苗取得喜人结果

2020-02-10

zhouqu_8 (审核中...)

前往app查看评论内容

#个体化#

椎动脉夹层动脉瘤的个体化栓塞治疗

2019-12-08

zhouqu_8 (审核中...)

前往app查看评论内容

#个体化#

北京精准用药研究与应用中心成立助推实现个体化用药

2019-11-12

zhouqu_8 (审核中...)

前往app查看评论内容

#个体化#

【CHC2019】个体化治疗是老年高血压管理的“灵魂”

2019-11-10

zhouqu_8 (审核中...)

前往app查看评论内容

#个体化#

J Clin Oncol:个体化内分泌辅助治疗让绝经前HR+/HER2-乳腺癌患者**获益

2019-11-03

zhouqu_8 (审核中...)

前往app查看评论内容

#个体化#

Nat Med：肿瘤全基因组测序助力癌症个体化治疗

2019-10-31

zhouqu_8 (审核中...)

前往app查看评论内容

#个体化#

靶向新药百花齐放，NSCLC治疗和奥希替尼耐药后治疗应更个体化

2019-10-17

zhouqu_8 (审核中...)

前往app查看评论内容

#个体化#

这些只能治疗一名患者的疗法，或将带来个体化医疗的新时代

2019-10-13

zhouqu_8 (审核中...)

前往app查看评论内容

#个体化#

Radiology：主动脉CTA--个体化触发延迟效果怎么样？

2019-09-23

zhouqu_8 (审核中...)

前往app查看评论内容

#个体化#

2019 CSCO：多项重磅研究成果发布，引领肿瘤个体化医疗新时代

2019-09-22

zhouqu_8 (审核中...)

前往app查看评论内容

#个体化#

精准治疗时代生物标志物助力肿瘤个体化诊疗

2019-07-29

zhouqu_8 (审核中...)

前往app查看评论内容

#个体化#

完全个体化肿瘤免疫疗法：一种针对个体化抗原的自体基因编辑的TCR T细胞疗法（NeoTCR-P1）

2019-07-23

zhouqu_8 (审核中...)

前往app查看评论内容

#个体化#

治愈时代的丙肝未来管理模式：个体化与精准化

2019-06-24

zhouqu_8 (审核中...)

前往app查看评论内容

#个体化#

2019 ASCO ：Moderna宣布其mRNA个体化癌症疫苗I期临床研究的中期阳性数据

2019-06-04

zhouqu_8 (审核中...)

前往app查看评论内容

#个体化#

溃疡性结肠炎的个体化治疗现状与展望

2019-05-25

智者为医08 (审核中...)

前往app查看评论内容

#个体化#

Acta Radiol：阜外医院吕滨等研究称，做冠脉CT时，个体化应用对比剂效果好

2019-05-22

zhouqu_8 (审核中...)

前往app查看评论内容

#个体化#

Diabetes Care：糖尿病个体化饮食计划——ADA的全新建议

2019-05-05

zhouqu_8 (审核中...)

前往app查看评论内容

#个体化#

Transgene与NEC在2019年合作开始个体化肿瘤疫苗TG4050的临床开发

2019-03-08

zhouqu_8 (审核中...)

前往app查看评论内容

#个体化#

Blood：多发性骨髓瘤治疗迈入“精准”时代——分子生物学检测指导个体化治疗

2019-02-11

科室
- - 订阅+
  - 更多科室
工具
服务